Previous work in several cancer cell lines, including the ovarian cancer cell line A2780/CP70, observed that FOXM1b had a higher transforming ability than FOXM1c and this is as measured by anchorage-independent growth [322]. This evidence concerns the gene FOXM1 and cancer.